Cover Image

Efficacy and Safety of Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients

Objective: It remains controversial whether to extend the course of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI). We conducted a study to investigate the benefits and risks of applying DAPT for different durations after PCI in acute coronary syndromes (ACS) patient...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jialun Han (Author), Yi Zhang (Author), Xiujin Shi (Author), Baidi Lin (Author), Yunnan Zhang (Author), Ru Zhang (Author), Yifan Wang (Author), Jialin Yan (Author), Yang Lin (Author)
Format:	Book
Published:	Ubiquity Press, 2023-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2019)

From Coronaries to Cirrhosis: The Role of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in End-Stage Liver Disease
by: Taylor C. Remillard MD, et al.
Published: (2021)

P2Y12 Inhibitor Monotherapy versus Conventional Dual Antiplatelet Therapy in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Meta-Analysis
by: Wen-Han Feng, et al.
Published: (2023)

Impact of Implementing CYP2C19 Genotype-Guided Antiplatelet Therapy on P2Y12 Inhibitor Selection and Clinical Outcomes in Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention: A Real-World Study in China
by: Yi Zhang, et al.
Published: (2021)

Precision Antiplatelet Therapy after Percutaneous Coronary Intervention (Precision PCI) Registry - Informing optimal antiplatelet strategies
by: Larisa H. Cavallari, et al.
Published: (2024)

Comparative efficacy and safety of antiplatelet or anticoagulant therapy in patients with chronic coronary syndromes after percutaneous coronary intervention: A network meta-analysis of randomized controlled trials
by: Yaowang Lin, et al.
Published: (2022)

Modern Antiplatelet Therapy for Percutaneous Coronary Intervention. How to Make the Right Choice?
by: T. M. Uskach, et al.
Published: (2020)

Cost-utility analysis of genotype-guided antiplatelet therapy in patients with moderate-to-high risk acute coronary syndrome and planned percutaneous coronary intervention
by: Patel V, et al.
Published: (2014)

Novel insights on dual antiplatelet therapy duration following stenting for angiography-detected moderate-to-severe calcified coronary lesions
by: Zhangyu Lin, et al.
Published: (2024)

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015)

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015)

Short vs Standard Duration Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with New-Generation Drug-Eluting Stents: A Meta- Analysis
by: Inam Ullah, et al.
Published: (2024)

Bivalirudin plus loading dose of cilostazol-based triple-antiplatelet in treatment of non-ST-elevation myocardial infarction following percutaneous coronary intervention
by: Wang M, et al.
Published: (2015)

Dual Antiplatelet Therapy Duration in Acute Coronary Syndrome Patients: The State of the Art and Open Issues
by: Monica Verdoia, et al.
Published: (2020)

Impact of Routine Platelet Reactivity Testing with VerifyNow Assay on Antiplatelet Choice After Percutaneous Coronary Intervention
by: Mshelbwala FS, et al.
Published: (2020)

Efficacy and safety of concomitant use of proton pump inhibitors with aspirin-clopidogrel dual antiplatelet therapy in coronary heart disease: A systematic review and meta-analysis
by: Xiaofeng Luo, et al.
Published: (2023)

The impact of dual antiplatelet therapy administration on the risk of bleeding complications during coronary artery bypass surgery
by: Paolo Nardi, et al.
Published: (2021)

Critical Appraisal of Guidelines for Antithrombotic Therapy in Atrial Fibrillation Post-Percutaneous Coronary Intervention
by: Yongqiang Fan, et al.
Published: (2022)

The Therapeutic Efficacy of Danhong Injection Combined With Percutaneous Coronary Intervention in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
by: Jun-Bo Zou, et al.
Published: (2018)

Short vs prolonged dual antiplatelet treatment upon endovascular stenting of peripheral arteries
by: Kronlage M, et al.
Published: (2017)

Effects of multidisciplinary exercise management on patients after percutaneous coronary intervention: A randomized controlled study
by: Ya-Jie Shi, et al.
Published: (2022)

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: What is new?
by: Zeki Öngen
Published: (2018)

Effect of Calcium Channel Blockers on Antiplatelet Activity of Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention: Insights from the PTRG-DES Consortium
by: HoungBeom Ahn MD, et al.
Published: (2024)

CHOICE OF ANTIPLATELET THERAPY IN VARIOUS PATIENTS WITH ACUTE CORONARY SYNDROMES
by: E. P. Panchenko
Published: (2015)

The Conundrum of Anticoagulation and Antiplatelet Therapy in Spontaneous Coronary Artery Dissection
by: Andres Cordova Sanchez MC, et al.
Published: (2022)

Persistent risk of vascular complications and efficacy of prolonged dual antiplatelet therapy after myocardial infarction
by: I. S. Yavelo
Published: (2022)

Factors contributing to exercise tolerance in patients with coronary artery disease undergoing percutaneous coronary intervention
by: Husheng Li, et al.
Published: (2023)

Stent thrombosis associated with drug eluting stents on addition of cilostazol to the standard dual antiplatelet therapy following percutaneous coronary intervention: a systematic review and meta-analysis of published randomized controlled trials
by: Feng Huang
Published: (2018)

Residual Dyslipidemia Leads to Unfavorable Outcomes in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention
by: Bin Que, et al.
Published: (2016)

Comorbidities and Percutaneous Coronary Intervention in Elderly Patients with Acute Coronary Syndrome
by: M. Yu. Gilyarov, et al.
Published: (2021)

Adherence to prophylactic dual antiplatelet therapy in patients with acute coronary syndrome - A study conducted at a Saudi university hospital
by: Ziyad Alrabiah, et al.
Published: (2020)

ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS
by: V. A. Sulimov
Published: (2016)

INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
by: K. B. Mirzaev, et al.
Published: (2015)

INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
by: K. B. Mirzaev, et al.
Published: (2015)

Safety and Feasibility of Same Day Discharge Strategy for Primary Percutaneous Coronary Intervention
by: Jehangir Ali Shah, et al.
Published: (2021)

Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome
by: Son V Pham, et al.
Published: (2010)

Acute Coronary Syndrome Treated with Percutaneous Coronary Intervention in Hutchinson-Gilford Progeria
by: Luciano De Simone, et al.
Published: (2023)

The quality of life of patients with coronary artery disease after percutaneous coronary interventions
by: Karolina Hajduga, et al.
Published: (2023)

Left main coronary disease percutaneous coronary intervention: The quest to reconcile the inconsistencies
by: Juan F. Iglesias, et al.
Published: (2021)

A late complication of coronary artery perforation during primary percutaneous coronary intervention: Coronary arteriovenous fistula
by: Kayıhan Karaman, et al.
Published: (2017)